Quick facts
- Face shield use scales with clinician-days, not patient volume: one shield per clinician per session is the unit most clinics actually order against.
- A box holds 24 individually wrapped shields and a 10-box case holds 240, so a four-clinician practice running two sessions a day is looking at roughly one box a week, not one box a month.
- The decisive variable is not the patient mix but the reuse policy: a clinic that treats a shield as single-use per session orders three to five times what a clinic that keeps one shield per clinician per day orders.
- Canada's national eye and face protector standard, CSA Z94.3:26, explicitly excludes biohazards and bioaerosols from its scope, and its predecessor stated that it does not address surgical or medical face shields used against interpersonal contamination — a distinction most buyers have never been told.
- In the United States the comparable gap is filled by ANSI/ISEA Z87.62-2021, which addresses protection against sprays or spurts of blood and other potentially infectious materials, and Z87.1-2025 now cross-references it.
- What an inspector checks is not the number of shields but the decision behind it: a written policy, a training record, and evidence that a damaged shield was replaced rather than worn.
Face shields sit in an awkward place in clinic procurement: they are bought by the box, used by the session, and justified by a risk assessment nobody writes down. The result is that two clinics with identical procedure lists order wildly different quantities, and neither can explain the difference when a manager asks. The product this page works through is the anti-fog PET face shield, individually wrapped, 240 per 10-box case; the arithmetic below applies to any individually wrapped shield, and the standards discussion applies to any shield a Canadian clinic is considering.
What does a month of face shields actually measure?
It measures clinician-sessions, not patients.
A face shield protects the wearer, so its consumption follows the number of people wearing one and the number of times they put a fresh one on. Four clinicians working two sessions a day for 20 days is 160 clinician-sessions. At one shield per session that is 160 shields a month — six and a half boxes. At one shield per clinician per day it is 80 — three and a third boxes. At one shield per clinician per week it is 16 — under one box.
That spread is the whole question. The rest of this page is about how to choose which of those three policies is defensible, and how to write it down so the order follows the policy rather than a habit.
How many shields are in a box, and what does a case cover?
Twenty-four to a box, 240 to a 10-box case. The table below converts clinician-sessions into both units.
| Clinic profile | Clinicians | Sessions per day | Operating days | Shields per month (one per session) | Boxes of 24 | 10-box cases |
|---|---|---|---|---|---|---|
| Single-chair dental practice | 2 | 2 | 20 | 80 | 3.3 | 0.33 |
| Four-room medical clinic | 4 | 2 | 21 | 168 | 7.0 | 0.70 |
| Dental practice with hygiene rooms | 6 | 2 | 20 | 240 | 10.0 | 1.00 |
| Multi-site group, shared supply | 10 | 2 | 22 | 440 | 18.3 | 1.83 |
Two things follow from reading the last two columns together. First, the case is the natural ordering unit for anything above six clinicians: at 240 shields it is one month of single-use-per-session cover for a six-clinician practice, and buying by the box means reordering every week. Second, par level belongs in weeks of cover: a clinic that holds two cases holds eight weeks at the four-clinician profile, which is comfortable for a product with a printed shelf life and excessive for a storeroom with no rotation.
What decides whether a shield is single-use or reused?
The manufacturer's instructions, then the clinic's risk assessment — in that order.
If the shield is labelled single-use, the clinic does not get to invent a cleaning protocol for it. If it is labelled reusable, the instructions for use say what cleaning is acceptable and how many cycles are supported. Public Health Ontario's routine practices framework puts the decision where it belongs: personal protective equipment is selected according to a risk assessment of the task, and it is changed when it becomes contaminated, damaged or no longer effective.
That gives a defensible three-tier policy, which is what most clinics converge on once they write it down:
| Situation | What the policy says | Effect on monthly volume |
|---|---|---|
| Shield visibly contaminated or damaged | Replace immediately, irrespective of schedule | Adds a small, unpredictable margin |
| High-splatter procedure (ultrasonic scaling, surgical extraction, irrigation) | New shield per patient | Drives volume toward the single-use line |
| Low-splatter examination or interview | One shield per clinician per session, wiped only if the manufacturer permits it | Cuts volume by half or more |
The middle row is where the money is. A clinic that applies the high-splatter rule to every appointment will order two to three times what its actual exposure requires, and an auditor reading the policy will notice that the rule and the procedure list do not match.
How does face shield guidance differ between Canada and the United States?
The hardware is identical; the standard underneath it is not.
Canada has a national standard for eye and face protectors, and it is explicit about what it does not cover. CSA Z94.3:26, the tenth edition, supersedes the 2020 edition and lists among its major changes the exclusion of hazards such as bioaerosols and biohazards from its scope. The edition it replaced said the quiet part out loud: Z94.3 has addressed protective face shields since the 1960s for impacts, dust and chemical splash, but "does not specifically address surgical/medical face shields used to protect against interpersonal contamination and infection."
In the United States the equivalent gap is narrower, because ANSI/ISEA Z87.1-2025 — the current edition, published in January 2026 — cross-references ANSI/ISEA Z87.62-2021, the standard addressing protection against sprays or spurts of blood and other potentially infectious materials. A Canadian buyer comparing a "Z87" shield with a plain medical shield is therefore comparing two different things: one is a protector tested against a hazard class, the other is a barrier chosen for a task.
| Item | Canada | United States |
|---|---|---|
| National eye and face protector standard | CSA Z94.3:26, tenth edition, supersedes the 2020 edition | ANSI/ISEA Z87.1-2025 |
| Does that standard cover biohazards? | Excluded from scope in Z94.3:26 — bioaerosols and biohazards are named exclusions | Z87.1-2025 cross-references ANSI/ISEA Z87.62-2021 for blood and other potentially infectious materials |
| Medical or surgical face shields | Not addressed by Z94.3; the manufacturer's instructions and the clinic's risk assessment govern | Covered through the Z87.62 reference and the device instructions for use |
| Workplace duty | Provincial occupational health and safety duties, plus provincial infection prevention guidance | OSHA eye and face protection (29 CFR 1910.133) and bloodborne pathogens (29 CFR 1910.1030) |
| Who pays | Employer duties under provincial law; many clinics supply PPE as policy | Employer must provide required PPE at no cost to the employee under the bloodborne pathogens standard |
| Product labelling | Medical Devices Regulations s.21(1) items, with language rules in s.23 | FDA device labelling requirements |
The fifth row is the one that changes behaviour. In the United States the "at no cost" framing is a federal requirement attached to the bloodborne pathogens standard; in Canada the equivalent duty runs through provincial occupational health and safety law, and the practical consequence — the clinic buys the shields and does not charge staff for them — is the same. What differs is the document a clinic points to.
Which standard should a Canadian clinic cite compared with an American clinic?
A Canadian clinic cites the manufacturer's instructions and its own risk assessment, and treats CSA Z94.3 as an occupational protector standard rather than a medical barrier standard. An American clinic can cite ANSI/ISEA Z87.1-2025 together with Z87.62-2021 where blood or other potentially infectious material is a hazard.
That difference matters at exactly one moment: when a buyer is comparing two shields and one carries a protector marking. A shield with a Z87 marking and a drop rating is being sold as an occupational protector; a shield sold for clinical use without that marking is being sold as a barrier against splatter, and its performance claim sits in the manufacturer's documentation rather than in a test standard. Neither is automatically wrong — but a clinic that buys the occupational protector for a procedure with no impact hazard is paying for testing it does not need, and a clinic that buys an unmarked barrier for a task with a splash hazard is relying on a claim nobody has tested.
What does an inspector ask about face shields?
Three things, none of which is a count.
The first is the policy: written, dated, and specific enough to say when a shield is replaced. The second is the training record, because a policy nobody was taught is not a practice. The third is the stock and disposal trail — shields available in the rooms where they are needed, and a waste route for used ones that matches the clinic's infection prevention policy.
A clinic that can produce those three can answer the follow-up question — "how many do you use?" — with a number it can defend, because the number is the product of the policy rather than an average.
What goes wrong most often?
Four failures, and the first is a purchasing failure rather than a clinical one.
Buying by the box when the clinic runs on cases produces weekly reorders, which is where stock-outs come from. Applying the high-splatter rule to every appointment doubles or triples consumption without changing exposure. Reusing a shield past the point where the manufacturer's instructions allow it turns a cheap item into an infection prevention finding. And storing wrapped shields in a hot room softens the anti-fog coating and the PET sheet itself, which is a quality failure a clinic discovers at the worst moment — when a clinician puts one on and cannot see.
Each has a one-line fix: order in cases, match the policy to the procedure list, follow the instructions for use, and keep stock out of heat.
Sources
- CSA Group — CSA Z94.3:26, Eye and face protectors (tenth edition; scope changes)
- CSA Group — CSA Z94.3:20, Eye and face protectors (ninth edition; face shield scope note)
- ANSI Webstore — ANSI/ISEA Z87.1-2025, Occupational and educational personal eye and face protection devices
- ANSI — ANSI/ISEA Z87.1-2025: current standard for safety glasses and the Z87.62 cross-reference
- ISEA — release note for ANSI/ISEA Z87.1-2025
- 29 CFR 1910.133 — Eye and face protection
- 29 CFR 1910.1030 — Bloodborne pathogens
- Public Health Ontario — routine practices and additional precautions in health care
- Public Health Ontario — infection prevention and control
- Public Health Ontario — IPAC checklist for clinical office practice
- Medical Devices Regulations, SOR/98-282 — labelling (s.21) and language (s.23) — read 2026-11-08
- Health Canada — Medical Devices Active Licence Listing (MDALL)
- ISO 14971:2019 — Application of risk management to medical devices
- ISO 13485:2016 — Medical devices: quality management systems
- CDC — guide to infection prevention for outpatient settings
- IPAC Canada — infection prevention and control resources
- FDA — device classification database
The free compliance log pack includes a dated PPE issue and replacement sheet, and the log generator on the same page prints a sheet for the current month. A clinic that wants its shield policy and stock levels reviewed together can ask for an institutional account review rather than re-derive the number each quarter. Reselling? become a distributor.
Related reading
- Face shield vs goggles: choosing eye protection for procedures
- Individually wrapped face shields: hygiene advantages for clinics
CliniEco Medical supplies face shields and clinic protective equipment in Canada under MDEL #35334. This page describes selection and stock practice; the requirements that bind a clinic are those of its regulator, its provincial occupational health and safety authority, its provincial infection prevention guidance and the manufacturer's instructions for use. Institutional account enquiries go through the account enquiry page.
Frequently Asked Questions
How many face shields does a Canadian clinic use in a month?
There is no published figure. The count follows clinician-sessions: clinicians multiplied by sessions per day and operating days, at one shield per session for single-use practice. A four-clinician clinic running two sessions a day over 21 days reaches about 168 shields, which is seven boxes of 24.
Are face shields single-use?
It depends on the label. A shield marked single-use is not cleaned and put back, whatever the clinic's budget pressure. A shield sold as reusable carries instructions for use that define the accepted cleaning method and the number of cycles supported, and those instructions set the limit.
Does CSA Z94.3 cover medical face shields?
No. CSA Z94.3:26, the current tenth edition, names bioaerosols and biohazards among its exclusions, and the previous edition stated that the standard does not specifically address surgical or medical face shields used to protect against interpersonal contamination and infection. For clinical use, the manufacturer's instructions and the clinic's risk assessment govern.
What standard applies in the United States?
ANSI/ISEA Z87.1-2025 is the current eye and face protection standard, and it cross-references ANSI/ISEA Z87.62-2021, which addresses protection against sprays or spurts of blood and other potentially infectious materials. OSHA's eye and face protection standard and bloodborne pathogens standard apply to the employer's duty.
How should a clinic decide between one shield per session and one per day?
By the procedure list. High-splatter tasks — ultrasonic scaling, surgical extraction, irrigation — justify a new shield per patient, while low-splatter examinations do not. Writing the two lists down and attaching a rule to each is what turns a habit into a defensible policy.
Do face shields expire?
Individually wrapped shields carry a manufacturer-assigned shelf life, and the label must show the expiry date where the device has one (s.21(1)(g)). Store them away from heat, rotate by date, and record the date the box was opened so the stock on the shelf can be dated at a glance.